TransMedics (TMDX) Gross Profit (2018 - 2026)

TransMedics has reported Gross Profit for 9 years, with the latest figure at $101.2 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 14.66% year-over-year to $101.2 million; the trailing twelve-month figure through Mar 2026 stood at $375.7 million (up 29.41% YoY), and the FY2025 full-year result was $362.8 million, up 38.43% from the prior year.
• Gross Profit for Q1 2026 stood at $101.2 million, up from $93.4 million in the prior quarter.
• The five-year high for Gross Profit was $101.2 million in Q1 2026, with the low at $12.1 million in Q1 2022.
• Average Gross Profit over 5 years is $55.6 million, with a median of $60.0 million recorded in 2024.
• Year-over-year, Gross Profit jumped 380.12% in 2022 and increased 14.66% in 2026.
• Tracing TMDX's Gross Profit over 5 years: stood at $20.7 million in 2022, then jumped by 131.48% to $47.9 million in 2023, then jumped by 50.27% to $72.0 million in 2024, then climbed by 29.72% to $93.4 million in 2025, then increased by 8.29% to $101.2 million in 2026.
• The last three Gross Profit figures came in at $101.2 million (Q1 2026), $93.4 million (Q4 2025), and $84.6 million (Q3 2025), per Business Quant data.

Peer Comparison